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Diffuse idiopathic pulmonary neuroendocrine cell hy-perplasia (DIPNECH) is regarded as a precursor to thedevelopment of carcinoid tumorlet and carcinoid tu-mor. It is conﬁned to the neuroendocrine cell hyper-
plasia of the airway mucosa without penetration through the base-
ment membrane and appears in a diffuse pattern, typically in
association with obliterative bronchiolar ﬁbrosis. DIPNECH be-
longs to the preinvasive lesions deﬁned by the 1999 World Health
Organization classiﬁcation, including atypical adematous hyper-
plasia and squamous dysplasia–carcinoma in situ.
Clinical Summary
A 73-year-old female nonsmoker was known to have intermittent
hemoptysis for several years. The family history and past medical
history were noncontributory beside a chronic dry cough in part
accompanied by mucous expectoration and a higher frequency of
pulmonary infections in the past years.
Previous chest radiography showed no underlying causes of the
clinical symptoms anamnestically. Contrast-enhanced spiral chest
computed tomographic examination revealed no apparent tumor
mass. Although bronchiectasis was multisegmental, the middle
lobe appeared to be most affected (Figure 1). During an acute
episode of hemoptysis, bronchoscopy revealed the superior seg-
mental bronchus (B6) of the right lobe to be the source of bleeding.
Spirometry revealed a forced expiratory volume in 1 second of
69.1% of predicted value, a forced vital capacity of 78.5% of
predicted value, and a forced expiratory volume in 1 second/forced
vital capacity ratio of 0.73. Because of the severe episodes of
hemorrhages and recurrent chest infections, the patient was sched-
uled to undergo thoracotomy.
No endobronchial lesion or bleeding was seen at repeated
bronchoscopy before intubation for pulmonary resection. Subtotal
obstruction of the right middle lobe was caused by mucus. For a more
limited resection, the patient underwent a right middle lobectomy
and systematic mediastinal and hilar lymph node dissection.
Pathology revealed diffuse neuroendocrine cell hyperplasia,
especially in the peribronchial region (Figure 2), as well as tumor-
let formation and a 1.2-cm typical carcinoid tumor. The resected
hilar and mediastinal lymph nodes were negative for metastatic
disease and had normal lymph node architecture. The postopera-
tive recovery was uneventful, and 3 months after surgical inter-
vention, she is stable with no pulmonary nodules on chest radiog-
raphy.
Discussion
DIPNECH is a rarely described lesion. The term diffuse idiopathic
pulmonary neuroendocrine cell hyperplasia refers to collections of
scattered single cells, small nodules, or linear proliferations of
neuroendocrine cells conﬁned to the airway mucosa. It is reserved
only for cases in which the hyperplasia is diffuse and primary in
nature. It is regarded as a precursor to the development of carci-
noid tumorlet (diameter 5 mm) or carcinoid tumor (diameter 5
mm). The diagnosis requires the presence of hyperplasia of the
airway neuroendocrine cells without invasion beyond the base-
ment membrane. It occurs in association with chronic inﬂamma-
tion or ﬁbrosis.1
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Figure 1. Computed tomographic scan showing noncharacteristic
inﬁltrates and bronchiectasis of the middle lobe.
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Clinical symptoms, speciﬁc pathologic features, and the re-
ported predilection for middle-aged or older nonsmoking women
matched with the ﬁnding of DIPNECH.3,4 This is consistent with
publications by Rufﬁni and associates2 and Swigris and col-
leagues.3
The role of hormonal modulation in this disease has been
suggested by Swigris and colleagues,3 but further studies are
pending.
In our case the serum neuron-speciﬁc enolase level was within the
normal values; nevertheless, the results of the immunohistochemical
examination of the tissue was positive for neuron-speciﬁc enolase.
The clinical picture of obliterative bronchiolitis and airway hyper-
reactivity is thought to be correlated to peptide secretory sub-
stances. Because hyperplastic neuroendocrine cells contain a va-
riety of neuropeptides, including bombesin-like peptides, these are
likely to be important in the pathogenesis.4
Although there are few reported cases, the prevalence of
DIPNECH might be higher than it is supposed to be because there
were no deﬁnition criteria until very recently, and the issue re-
mains controversial.2 A high index of suspicion is required to
recognize this entity.3
Little is known of the clinical evolution and treatment options
for DIPNECH. Therefore Swigris and colleagues3 presented 4
patients with 2- to 14-year follow-up and found an excellent
long-term prognosis.
The management of patients with DIPNECH is predominantly
close surveillance; the role of surgical intervention is not clearly
deﬁned. Worsening of obstructive symptoms (or in our case re-
current pulmonary hemorrhage) can be dealt with by means of
palliative resection. In patients with carcinoid tumor formation,
complete resection of the carcinoid tumor with lung preservation
surgery, accompanied by a systematic mediastinal and hilar lymph
node dissection, forms the basic treatment opinion.
In patients in whom DIPNECH continues to progress to carci-
noid tumors and in whom surgical options run out, somatostatin
analogs and interferon  might have a role as tumerostatic agents.5
In conclusion, long-term follow up is mandatory to detect the
formation of early carcinoid tumors.
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Figure 2. Microscopic appearance of DIPNECH: small groups and
nodular aggregates of tumor cells associated with the bronchio-
lar epithelium. (Original magniﬁcation 40; hematoxylin and eo-
sin staining.)
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